Active, Not Recruiting
A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain
NCT06746116
- Conditions
- Advanced or Recurrent Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
- Locations
-
- Research Site A Coruña, Spain
- Research Site Alicante, Spain
- Research Site Barakaldo, Spain
- Research Site Barcelona, Spain